Alcon Inc.
NYSE:ALCMedical - Instruments & Supplies
+$0.61 today
- Market cap
- $36.15B
- Beta
- 0.70
- P/E (TTM)
- 38.7
- EPS (TTM)
- $1.67
- Dividend yield
- 0.55%
Volume 4.74M
Average 1.91M
ALC Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Alcon Inc.NYSE: ALC
Revenue · Q3 FY2026 · quarter ended Sep 2026
Revenue grows, but more slowly than its trailing trend
Q3 FY2026 revenue of $2.74B rose 4.7% year over year, behind the +7.3% change in trailing-twelve-month revenue. Sequentially, it fell 3.0% from the prior quarter. Over 3 fiscal years it compounded at +6.1% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 12 analysts of $10.93B (+5.1%) for the fiscal year ending Dec 2026, a pace similar to FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $2.74B-3.0% QoQ
- Last fiscal yearDec 2025
- $10.4B+4.9% YoY
- LTMSep 2026
- $10.93B+7.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +4.7% | +3.4% | -1.3 pp |
| 1 year | +4.9% | +5.1% | +0.2 pp |
| 3-year CAGR | +6.1% | +5.6% | -0.5 pp |
| 5-year CAGR | +5.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 10.4B USD
- Year-over-year change
- +4.9%
- 4-year CAGR
- +5.8%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.4B | +4.9% |
| FY2024 | 2024-12-31 | 9.91B | +4.8% |
| FY2023 | 2023-12-31 | 9.46B | +8.5% |
| FY2022 | 2022-12-31 | 8.72B | +5.1% |
| FY2021 | 2021-12-31 | 8.29B | — |
Revenue vs competitors
How ALC compares with its peers on the latest reported figures
- ALC's LTM Sep 2026 revenue of $10.93B is the highest of the 8 companies compared; the peer median is $290.38M.
- Its year-over-year change of +7.3% is the 3rd highest of 8, against a peer median of +4.0%.
- Over three fiscal years its annual growth of +6.1% compares with a peer median of +10.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $10.93B | +7.3% | +6.1% | |
| LTM Jun 2026 | $5.32B | +8.8% | +10.6% | |
| LTM Jul 2026 | $4.24B | +4.7% | +7.3% | |
| LTM Jun 2026 | $612.84M | +41.5% | +21.5% | |
| LTM Apr 2026 | $290.38M | +4.0% | -5.6% | |
| LTM Mar 2026 | $127.48M | -19.5% | +40.0% | |
| LTM Mar 2026 | $79.55M | +1.8% | +2.7% | |
| LTM Mar 2026 | $57.7M | +1.1% | +18.2% | |
| Peer median (excluding ALC) | $290.38M | +4.0% | +10.6% | |
Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 8.29B | 8.72B | 9.46B | 9.91B | 10.4B |
| Cost of Revenue | 3.64B | 3.97B | 4.21B | 4.4B | 4.66B |
| Gross Profit | 4.65B | 4.75B | 5.25B | 5.51B | 5.75B |
| Gross Margin | 56.1% | 54.5% | 55.5% | 55.6% | 55.2% |
| Research & Development | 842M | 702M | 859M | 876M | 990M |
| Selling, General & Admin | 3.08B | 3.07B | 3.21B | 3.25B | 3.45B |
| Operating Expenses | 4.07B | 4.08B | 4.21B | 4.1B | 4.39B |
| Depreciation & Amortization | 1.22B | 1.12B | 1.22B | 1.23B | 1.34B |
| EBITDA | 1.76B | 1.74B | 2.24B | 2.68B | 2.5B |
| EBITDA Margin | 21.2% | 20.0% | 23.7% | 27.0% | 24.0% |
| Operating Income | 580M | 672M | 1.04B | 1.41B | 1.36B |
| Operating Margin | 7.0% | 7.7% | 11.0% | 14.3% | 13.1% |
| Interest Income | 3.01M | 16.52M | 34M | 81.45M | 74M |
| Interest Expense | 120.26M | 138.4M | 189M | 186.18M | 204M |
| Other Income / Expenses | (162M) | (209M) | (207M) | (157M) | (200M) |
| Income Before Tax | 418M | 463M | 832M | 1.26B | 1.16B |
| Pre-Tax Margin | 5.0% | 5.3% | 8.8% | 12.7% | 11.2% |
| Income Tax Expense | 42M | 128M | (142M) | 238M | 180M |
| Net Income | 376M | 335M | 974M | 1.02B | 980M |
| Net Margin | 4.5% | 3.8% | 10.3% | 10.3% | 9.4% |
| EPS (Basic) | 0.77 | 0.68 | 1.98 | 2.06 | 1.99 |
| EPS (Diluted) | 0.76 | 0.68 | 1.96 | 2.05 | 1.98 |
| Weighted Avg Shares | 490M | 491.4M | 493M | 494.4M | 494.95M |
| Weighted Avg Shares (Diluted) | 493.4M | 494.4M | 496.5M | 497.5M | 496.2M |
Alcon Inc.
NYSE:ALC
Intrinsic Alpha fair value
Locked
Current Price
$75.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.